Since SLFN11 is known to sensitize cancer cells to a number of drugs that cause DNA-damage, including DNA synthesis inhibitors, we tested the hypothesis that the sensitivity of Ewing sarcoma cells to RNR inhibitors may be caused by elevated levels of SLFN11 [39, 41]. Here, SLFN11 is linked to Ewing sarcoma.